Kubota, T., Miyake, K., & Hirasawa, T. (2013). Role of epigenetics in Rett syndrome. Epigenomics, 5(5), 583-592. doi: 10.2217/epi.13.54
Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2.
Huppke, P. (2000). Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Human Molecular Genetics, 9(9), 1369-1375. doi: 10.1093/hmg/9.9.1369
Gold, W. A., Krishnarajy, R., Ellaway, C., & Christodoulou, J. (2018). Rett Syndrome: A Genetic Update and Clinical Review Focusing on Comorbidities. ACS chemical neuroscience, 9(2), 167–176. https://doi.org/10.1021/acschemneuro.7b00346
Kyle, S. M., Vashi, N., & Justice, M. J. (2018). Rett syndrome: a neurological disorder with metabolic components. Open biology, 8(2), 170216. https://doi.org/10.1098/rsob.170216
Vidal, S., Xiol, C., Pascual-Alonso, A., O’Callaghan, M., Pineda, M., & Armstrong, J. (2019). Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges. International journal of molecular sciences, 20(16), 3925. https://doi.org/10.3390/ijms20163925